| by Álvaro Mendiola | Sep 18, 2024 | News
The first half of the year has not been as good as forecasts expected, but macroeconomic factors augur a recovery of the M&A market by the end of 2024, despite the current uncertainty. Exit pressure is growing because the more time passes with a reduced number of...
| by Álvaro Mendiola | Aug 7, 2024 | News
The foreign direct investment (FDI) regime is essential in the context of mergers and acquisitions because it creates control and cooperation mechanisms between EU Member States. The recent Royal Decree 571/2023 creates a new regulatory framework for foreign...
| by Álvaro Mendiola | Jul 10, 2024 | News
Law 4/2023 established 2 March 2024 as the deadline for all companies with more than 50 employees to have an LGTBI Plan in place. However, the specific content of this plan has not been specified until now, with the regulatory development of Article 15. On 26 June, an...
| by Álvaro Mendiola | Jun 26, 2024 | News
MAC clauses are a legal concept whose purpose is to cover the parties to a contract against the risk of a material adverse change that could frustrate the purpose of the contract or render it meaningless. In fact, their acronym corresponds to the English expression...
| by Álvaro Mendiola | Jun 12, 2024 | News
The pharmaceutical industry has a number of particularities that set it apart from other sectors. Pharmaceutical companies operate in a market that is highly regulated by the authorities. They require administrative authorisation to launch any medicine. Distribution,...
